← brief for 2026-09-04 · Slowing decline

Characteristics associated with efficacy of hypoxia-inducible factor-prolyl hydroxylase inhibitors in renal anemia patients: a retrospective cohort study

Paper C Peer reviewed Observational

Key takeaways

Doctors looked back at patients taking HIF-PHI pills, a newer treatment for the low blood count that comes with kidney disease, to work out who responds best. The study reports which patient traits went along with a stronger response. Because it looks backward at past records, it shows links only, not proof of cause. The record we received does not give the number of patients.

Who did this work

Yaxin Wang (Nanjing University of Chinese Medicine) · Lei Li (Nanjing University of Chinese Medicine) · Peiqi Zhu (Nanjing University of Chinese Medicine) · Weixiang Liu (Nanjing University of Chinese Medicine) · Xinghan Wang (Nanjing University of Chinese Medicine) · He Wei-Ming (Nanjing University of Chinese Medicine) · Tao Yang (Nanjing University of Chinese Medicine)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-03
https://doi.org/10.1186/s12882-026-05323-z